Monday, March 10, 2025

Healthcare

RenovoRx’s TAMP Platform Revolutionizes Cancer Therapy (Nasdaq: RNXT)

 ("RenovoRx" or the "Company") (Nasdaq: RNXT), is a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform.  Recently, the Company announced the...

NurExone’s Expands Commercialization Efforts with All-star Hire (TSXV: NRX)

NurExone (TSXV: NRX) (Germany: J90)  (the “Company” or “NurExone") is a pioneering biopharmaceutical company developing regenerative medicine therapies. For a quick catch up on NRX, here are...

Nurexone is on a Quest to Revolutionize Spinal Cord Injury Treatment

Nurexone Biologic Inc. leads the charge in developing cutting-edge exosome-based therapies for central nervous system injuries, particularly traumatic spinal cord injuries (tSCI), promising groundbreaking...

VistaGen Therapeutics (NASDAQ : VTGN) Analysis

 Vistagen (Nasdaq: VTGN) is a San Francisco-based biopharmaceutical company pioneering neuroscience. Its treatments deliver ground-breaking therapies for individuals affected by psychiatric and neurological disorders. Recently,...

NurExone Unlocks Several Milestones Since March 2024 (TSXV: NRX, FSE: J90, NRX.V)

● Leading the charge in exosome-based medicine, NurExone pioneers ExoTherapy, utilizing tiny cell-secreted particles to deliver treatments like ExoPTEN, focusing on spinal cord injury recovery — a...

Popular

Subscribe